Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

Researchers identified 5-hydroxytryptamine 2A (5-HT2A) receptor (5-HT2AR) signaling pathways associated with psychedelic potential.

Renck: The Sanders brothers look to live up to the hype – The Cannabist

Interviewing Shedeur Sanders and Shilo Sanders together at Wednesday’s Big 12 media day was equal parts informative and comedic. They definitely are brothers, even if

July 11, 2024

Two Doctors Charged in Connection With Matthew Perry’s Death

A federal prosecutor says five people have been charged in connection with Matthew Perry’s death from a ketamine overdose last year, including the actor’s assistant

August 16, 2024

Janssen seeks EMA approval for single tablet pulmonary arterial hypertension treatment – Pharmaceutical Technology

Pulmonary Arterial Hypertension patients are often restricted to complicated and difficult to adhere to treatment regimes. Source: Getty Images / FG Trade Johnson & Johnson’s

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.